In the News

Dec 23, 2014

Now Part of AstraZeneca, Definiens Concentrating on CDx, Ramp up into Clinical Space

Read More
Dec 12, 2014

Clinical trial data inaccuracies-Challenges for personalized medicine

Read More
Dec 1, 2014

An Interview with Thomas P. Heydler CEO of Definiens AG on the Recent Acquisition of Definiens by AstraZeneca

Read More
Nov 28, 2014

Definiens pioneers tissue imaging in oncology and personalized cancer treatment

Read More
Nov 20, 2014

Diagnostics: The Road to Lower Costs in Cancer Care

Read More